Article
The Promise of Epigenomic Therapeutics in Pancreatic Cancer
1 Jun 2016
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) is often viewed to arise primarily by genetic alterations. However, today we know that many aspects of the cancer phenotype require a crosstalk among these genetic alterations with epigenetic changes. Indeed, aberrant gene expression patterns, driven by epigenetics are fixed by altered signaling from mutated oncogenes and tumor suppressors to define the PDAC phenotype. This...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
